BY-23
N/A
Report date: 2022/01/05 15:24:33
Base Information
Drug NameBY-23
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Biyang Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesBeijing Biyang Biotechnology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A